EP1581176A2 - Preparations cosmetiques ou dermatologiques tres fluides de type huile-dans-eau - Google Patents

Preparations cosmetiques ou dermatologiques tres fluides de type huile-dans-eau

Info

Publication number
EP1581176A2
EP1581176A2 EP03796094A EP03796094A EP1581176A2 EP 1581176 A2 EP1581176 A2 EP 1581176A2 EP 03796094 A EP03796094 A EP 03796094A EP 03796094 A EP03796094 A EP 03796094A EP 1581176 A2 EP1581176 A2 EP 1581176A2
Authority
EP
European Patent Office
Prior art keywords
cosmetic
acid
preparations
oil
advantageous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP03796094A
Other languages
German (de)
English (en)
Inventor
Birgit Grotelueschen
Stephanie Von Der Fecht
Anja Eitrich
Ingo Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP1581176A2 publication Critical patent/EP1581176A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to low-viscosity, finely dispersed cosmetic and dermatological preparations of the oil-in-water type, in particular O / W hydrodispersions which have a viscosity of less than 2,000 mPa-s, and to their use for cosmetic and medical purposes. Furthermore, the present invention relates to cosmetic and dermatological wipes which are impregnated with such preparations.
  • Cosmetic and / or dermatological preparations are used in a wide variety of applications.
  • a wide range of products - such as lotions and creams - are available for skin care, especially for regreasing dry skin.
  • the aim of skin care is to compensate for the loss of fat and water in the skin caused by daily washing.
  • skin care products are intended to protect against environmental influences - especially sun and wind - and to delay skin aging.
  • auxiliaries are required to separate the two phases prevent, but at least delay until the emulsion has fulfilled its purpose.
  • these aids are intended to stabilize the interface by preventing the droplets of the disperse phase from flowing together. Ideally, these substances also cause the droplets to be rejected, which prevents them from approaching, so that aggregation can be avoided.
  • the auxiliaries are used to counteract the creaming or sedimentation of the phases.
  • emulsions generally contain organic emulsifiers which stabilize the emulsions or enable them to be prepared.
  • emulsifiers in cosmetic or dermatological preparations is harmless.
  • emulsifiers - like any chemical substance - can cause allergic or hypersensitive reactions in individual cases, it is desirable to keep the emulsifier content of a cosmetic or dermatological formulation as low as possible.
  • hydrodispersions In contrast to O / W emulsions, hydrodispersions, which are characterized by a similar phase arrangement, are essentially free of emulsifiers. Like emulsions, hydrodispersions represent metastable systems and are inclined to transition into a state of two interrelated discrete phases. Hydrodispersions are dispersions of a liquid, semi-solid or solid inner lipid phase in an outer aqueous phase.
  • Hydrodispersion systems are generally stabilized by thickeners which increase the viscosity of the aqueous phase.
  • Organic thickeners are suitable for this.
  • a disadvantage of this stabilization method is that naturally higher-viscosity formulations can be produced in this way.
  • Such systems are accordingly also referred to as hydrodispersion gels.
  • low-viscosity preparations of the prior art frequently have the disadvantage that they are limited to a narrow application range or a restricted selection of raw materials.
  • the incorporation of higher concentrations of polar oil components also often presents difficulties.
  • An object of the present invention was to produce emulsifier-free preparations of the oil-in-water type which have a very low viscosity and do not have the disadvantages of the prior art. It was also an object of the invention to find a method for stabilizing low-viscosity O / W formulations. Preparations should also be found which are suitable as impregnation solutions for cosmetic or dermatological wipes.
  • Soaked cloths are widely used as objects of daily use in various areas. Among other things, they allow efficient and skin-friendly cleaning and care, especially in the absence of (running) water.
  • the actual article of daily use consists of two components: a) a dry cloth, which is made of materials such as paper and / or various mixtures of natural or synthetic fibers, and b) a low-viscosity impregnation solution.
  • Cosmetic or dermatological wipes can consist of both water-soluble (e.g. toilet paper) and water-insoluble materials. Furthermore, the wipes can be smooth, perforated or also surface structured. Conventional impregnation or impregnation solutions for water-insoluble nonwoven materials have hitherto often had the lack of poor long-term stability. Emulsions tend to phase separate, especially at elevated ambient temperatures, which is a decisive disadvantage for the impregnation process and for the final quality of the end product.
  • low-viscosity preparations which are finely dispersed systems of the water-in-oil type and have a viscosity of less than 2,000 mPa-s, contain
  • the preparations contain significantly less than 0.5% by weight of one or more emulsifiers.
  • Preparations according to the invention which are completely free of emulsifiers in the conventional sense are very particularly preferred.
  • the preparations according to the invention are extremely satisfactory preparations which have a significantly lower viscosity than conventional hydrodispersions and are therefore particularly suitable for serving as the basis for preparation forms with a wide variety of uses. It was particularly surprising that the use of the thickeners according to the invention makes it possible to obtain low-viscosity preparations.
  • the preparations according to the invention are in every respect an enrichment of the prior art with regard to low-viscosity O / W emulsions. They represent formulations whose droplet size is not in the microemulsion range, ie. H. the average droplet size of the preparations according to the invention is greater than 1 ⁇ m.
  • hydrocolloids are macromolecules which have a largely linear shape and have intermolecular interaction forces which enable secondary and main valence bonds between the individual molecules and thus enable the formation of a network-like structure. They are partially water-soluble, water-dispersible natural or synthetic polymers that form gels or viscous solutions in aqueous systems. They increase the viscosity of the water by either binding water molecules (hydration) or by absorbing and enveloping the water in their intertwined macromolecules, while at the same time restricting the mobility of the water.
  • Hydrocolloids which are advantageous according to the invention are, for example, polymers of acrylic acid, in particular those selected from the group of the so-called carbomers or carbopoles (Carbopol® is actually a registered trademark of the B.F. Goodrich Company). Carbopols are compounds of the general structural formula
  • the carbopole group also includes acrylate-alkyl acrylate copolymers, for example those which are distinguished by the following structure:
  • R ' represents a long-chain alkyl radical and x and y numbers which symbolize the respective stoichiometric proportion of the respective comonomers. These carbopoles are also advantageous for the purposes of the present invention.
  • Examples of advantageous carbopoles are types 907, 910, 934, 940, 941, 951, 954, 980, 981, 1342, 1382, 2984 and 5984, it being possible for these compounds to be present individually or in any combination with one another.
  • Carbopol 981, 1382 and 5984 are particularly preferred (both individually and in combination with other hydrocolloids).
  • copolymers of C ⁇ o comparable to the acrylate-alkyl acrylate copolymers.
  • the INCI name for such compounds is "Acrylates / C 10-30 Alkyl Acrylate Crosspolymer”.
  • Particularly advantageous are those available under the trade names Pemulen TR1 and Pemulen TR2 from the BF Goodrich Company.
  • a preferred hydrocolloid for the purposes of the present invention is also xanthan (CAS No. 11138-66-2), also called xanthan gum, which is an anionic heteropolysaccharide which is generally formed from corn sugar by fermentation and is isolated as the potassium salt. It is produced by Xanthomonas campestris and some other species under aerobic conditions with a molecular weight of 2 * 10 ⁇ to 24 ⁇ 10 6 .
  • Xanthan is made from a chain with ß-1,4-bound glucose (Cellulose) formed with side chains.
  • the structure of the subgroups (“repeated units”) consists of glucose, mannose, glucuronic acid, acetate and pyruvate.
  • the total amount of one or more hydrocolloids according to the invention is advantageously chosen to be less than 0.5% by weight, preferably between 0.05 and 0.5% by weight, based in each case on the total weight of the preparations, in the finished cosmetic or dermatological hydrodispersions ,
  • hydrodispersions according to the invention contain further auxiliaries which can further increase the stability of these preparations, for example substances which are selected from the group of waxes and / or oil thickeners and electrolytes.
  • the cosmetic properties of the hydrodispersions according to the invention can additionally be improved, for example, by also using oils in the oil phase which have a viscosity which is less than 30 mPa-s, in particular less than 20 mPa-s (determined using a rheometer of Contraves (R eomat 108E) with a shear rate of 500 / s and a temperature of 25 ° C).
  • oils in the oil phase which have a viscosity which is less than 30 mPa-s, in particular less than 20 mPa-s (determined using a rheometer of Contraves (R eomat 108E) with a shear rate of 500 / s and a temperature of 25 ° C).
  • the cosmetic properties (in particular the wetting properties and the feeling on the skin) of the hydrodispersions according to the invention can additionally be determined by the use of chitosan (in concentrations of less than 1% by weight, in particular 0.1 to 0.5% by weight) and / or other cationic film formers such.
  • chitosan in concentrations of less than 1% by weight, in particular 0.1 to 0.5% by weight
  • / or other cationic film formers such.
  • B. Starch hydroxypropyltrimonium chloride, which is available under the trade name Sensomer Cl-50 from FA Ondeo Nalco, can be improved.
  • hydrodispersions according to the invention contain solubilizers; PPG-15 stearyl ether and PEG-40 hydrogenated castor oil are particularly advantageous.
  • the oil phase of the formulations according to the invention is advantageously chosen from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, especially the triglycerol esters of saturated and / or unsaturated, mixed branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 to 18, carbon atoms.
  • the fatty acid triglycerides can for example be advantageously selected from the group of synthetic, semi-synthetic and natural oils, such as. B.
  • cocoglyceride olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil and the like.
  • z. B natural waxes of animal and vegetable origin, such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax).
  • further advantageous polar oil components can also be selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms and from the group of esters from aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms.
  • ester oils can then advantageously be selected from the group octyl palmitate, octyl cocoate, octyl isostearate, octyl dodeceyl myristate, octyl dodecanol, cetearylisonononate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearylateolate, n-butyl stearylateolate, n-butyl stearate, n-butyl stearate, n-butyl-stearate, n-butyl-stearate, n-butyl-stearate, n-butyl-stearate, n-butyl-stearate, n-butyl-stearate, n-butyl-stearate, n-butyl-stearate,
  • the oil phase can advantageously be selected from the group of dialkyl ethers and dialkyl carbonates.
  • Advantageous oil components are also e.g. B. butyl octyl salicylate (for example that available under the trade name Hallbrite BHB from CP Hall), hexadecyl benzoate and butyl octyl benzoate and mixtures thereof (Hallstar AB) and / or diethyl hexyl naphthalate (Hallbrite TQ or Corapan TQ from H&R).
  • B. butyl octyl salicylate for example that available under the trade name Hallbrite BHB from CP Hall
  • hexadecyl benzoate and butyl octyl benzoate and mixtures thereof Hallstar AB
  • Hallbrite TQ or Corapan TQ from H&R diethyl hexyl naphthalate
  • the oil phase can also advantageously also contain nonpolar oils, for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohe- xadecan.
  • nonpolar oils for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohe- xadecan.
  • polyolefins polydecenes are the preferred substances.
  • the oil phase can advantageously also have a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or the silicone oils.
  • Silicone oils are high-molecular synthetic polymeric compounds in which silicon atoms are linked in a chain and / or network-like manner via oxygen atoms and the remaining valences of silicon by hydrocarbon residues (mostly methyl, more rarely ethyl, propyl, phenyl groups, etc.) are saturated.
  • the silicone oils are systematically referred to as polyorganosiloxanes.
  • the methyl-substituted polyorganosiloxanes which represent the most significant compounds in terms of quantity in this group and are characterized by the following structural formula
  • Dimethicone is available in different chain lengths or with different molecular weights.
  • Particularly advantageous polyorganosiloxanes for the purposes of the present invention are, for example, dimethylpolysiloxanes [poly (dimethylsiloxane)], which are available, for example, under the trade names Abil 10 to 10,000 from Th. Goldschmidt.
  • phenylmethylpolysiloxanes INCI: phenyl dimethicone, phenyl trimethicone
  • cyclic silicones octamethylcyclotetrasiloxane or decamethylcyclopentasiloxane
  • amino-modulated silicones INCI: Amodimethethone,. B.
  • polysiloxane-polyalkylene copolymers (INCI: stearyl dimethicone and cetyl dimethicone) and dialkoxydimethyl polysiloxanes (stearoxy dimethicone and behenoxy stearyl dimethicone), which are available as different Abil-Wax types from Th. Goldschmidt.
  • other silicone oils can also be used advantageously for the purposes of the present invention, for example cetyldimethicone, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
  • the preparations according to the present invention can furthermore advantageously contain one or more substances from the following group of siloxane elastomers, for example in order to increase the water resistance and / or the sun protection factor of the products:
  • Siloxane elastomers which contain the units R 2 SiO and RSiO ⁇ , s and / or 3 SiOo, 5 and / or Si0 2 , the individual radicals R each independently of one another being hydrogen, C ⁇ - 2 -AlK- (such as methyl , Ethyl, propyl) or aryl (such as phenyl or tolyl), alkenyl (such as vinyl) and the weight ratio of the units R 2 SiO to RSiO ⁇ , 5 is selected from the range from 1: 1 to 30: 1;
  • Siloxane elastomers which are insoluble and swellable in silicone oil and which can be obtained by the addition reaction of an organopolysiloxane (1) containing silicon-bonded hydrogen with an organopolysiloxane (2) containing unsaturated aliphatic groups, the proportions used being chosen so that the amount of hydrogen of the organopolysiloxane (1) or the unsaturated aliphatic groups of the
  • organopolysiloxane is not cyclic
  • is in the range of 1 to 50 mol% when the organopolysiloxane is cyclic.
  • the siloxane elastomer or elastomers are advantageously in the form of spherical powders or in the form of gels.
  • advantageous siloxane elastomers in the form of spherical powder are those with the INCI name Dimethicone / Vinyl Dimethicone Crosspolymer, for example that available from DOW CORNING under the trade name DOW CORNING 9506 Powder.
  • siloxane elastomer is used in combination with oils from hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof.
  • siloxane elastomer is used in combination with unbranched silicone oils which are liquid or pasty at room temperature or cyclic silicone oils or mixtures thereof.
  • Organopolysiloxane elastomers with the INCI name Dimethicone / Polysilicone-11 are particularly advantageous, especially the Gransil types GCM, GCM-5, DMG-6, CSE Gel, PM-Gel, LTX, ININ available from Grant Industries Inc. Gel, AM-18 gel and / or DMCM-5.
  • the siloxane elastomer is used in the form of a gel composed of siloxane elastomer and a lipid phase, the content of the siloxane elastomer in the gel being 1 to 80% by weight, preferably 0.1 to 60% by weight , each based on the total weight of the gel.
  • the total amount of the siloxane elastomers (active content) in the range from 0.01 to 10% by weight, advantageously from 0.1 to 5% by weight, in each case based on the total weight of the formulation, to choose.
  • the cosmetic and dermatological preparations according to the invention can contain dyes and / or color pigments, in particular if they are in the form of decorative cosmetics.
  • the dyes and pigments can be selected from the corresponding positive list in the Cosmetics Ordinance or the EC list of cosmetic colorants. In most cases, they are identical to the colorants approved for food.
  • Advantageous color pigments are, for example, titanium dioxide, mica, iron oxides (eg Fe 2 0 3 , Fe 3 0, FeO (OH)) and / or tin oxide.
  • Advantageous dyes are, for example, carmine, Berlin blue, chrome oxide green, ultramarine blue and / or manganese violet. It is particularly advantageous to choose the dyes and / or color pigments from the Rowe Color Index, 3rd edition, Society of Dyers and Colorists, Bradford, England, 1971.
  • the formulations according to the invention are in the form of products which are used on the face, it is advantageous to choose one or more substances from the following group as the dye: 2,4-dihydroxyazobenzene, 1- (2'-chloro-4'- nitro-1'-phenylazo) -2-hydroxynaphthalene, ceres red, 2- (sulfo-1-naphthylazo) -1-naphthol-4-sulfonic acid, calcium salt of 2-hydroxy-1,2'-azonaphthalene-1'- sulfonic acid, calcium and barium salts of 1- (2-sulfo-4-methyl-1-phenylazo) -2-naphthylcarboxylic acid, calcium salt of l - (2-sulfo-1-naphthylazo) -2-hydroxynaphthalene-3-carboxylic acid, aluminum salt 1- (4-sulfo-1-phenylazo) -2-naphthol-6-sulfonic
  • 2,4,5,7-tetrabromofluorescein and its aluminum salt aluminum salt of 2,4,5,7-tetra-iodofluorescein, aluminum salt of quinophthalone disulfonic acid, aluminum salt of indigo disulfonic acid, red and black iron oxide (CIN: 77 491 (red) and 77499 (black)), iron oxide hydrate (CIN: 77 492), manganese ammonium diphosphate and titanium dioxide.
  • Oil-soluble natural dyes such as e.g. B. paprika extracts, ß-carotene or cochineal.
  • Formulations containing pearlescent pigments are also advantageous for the purposes of the present invention.
  • the types of pearlescent pigments listed below are particularly preferred:
  • Natural pearlescent pigments such as. B.
  • Monocrystalline pearlescent pigments such as B. bismuth oxychloride (BiOCI) 3rd layer substrate pigments: e.g. B. mica / metal oxide
  • Pearlescent pigments are based, for example, on powdered pigments or castor oil dispersions of bismuth oxychloride and / or titanium dioxide and bismuth oxychloride and / or titanium dioxide on mica. Particularly advantageous is e.g. B. the gloss pigment listed under CIN 77163.
  • pearlescent pigment types based on mica / metal oxide are also advantageous:
  • B the pearlescent pigments available from Merck under the trade names Timiron, Colorona or Dichrona.
  • pearlescent pigments which are advantageous in the sense of the present invention can be obtained in numerous ways known per se.
  • other substrates besides mica can be coated with other metal oxides, such as. B. silica and the like.
  • Z are advantageous.
  • Iron pearlescent pigments which are produced without the use of mica are particularly preferred. Such pigments are e.g. B. available under the trade name Sicopeari copper 1000 from BASF.
  • effect pigments which are available from Flora Tech under the trade name Metasomes Standard / Glitter in various colors (yello, red, green, blue).
  • the glitter particles are present in mixtures with various auxiliaries and dyes (such as the dyes with the Color Index (Cl) numbers 19140, 77007, 77289, 77491).
  • the dyes and pigments can be present either individually or in a mixture and can be mutually coated, different color effects generally being produced by different coating thicknesses.
  • the total amount of dyes and coloring pigments is advantageously from the range of z. B. 0.1 wt .-% to 30 wt .-%, preferably from 0.5 to 15 wt .-%, in particular from 1.0 to 10 wt .-%, each based on the total weight of the preparations.
  • the hydrodispersions according to the invention can serve as the basis for cosmetic or dermatological formulations.
  • the cosmetic and dermatological preparations according to the invention are applied to the skin in a sufficient amount in the manner customary for cosmetics.
  • cosmetic or topical dermatological compositions within the meaning of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sunscreen lotion, nutritional cream, day or night cream, etc. It is possibly possible and advantageous to use the compositions according to the invention as the basis for pharmaceuticals Use wording.
  • the cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries as are usually used in such preparations, e.g. B. preservatives, preservation aids, complexing agents, bactericides, perfumes, substances to prevent or increase foaming, dyes, pigments that have a coloring effect, other thickeners, moisturizing and / or moisturizing substances, fillers that improve the skin feel, fats, oils , Waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic auxiliaries e.g. B. preservatives, preservation aids, complexing agents, bactericides, perfumes, substances to prevent or increase foaming, dyes, pigments that have a coloring effect, other thickeners, moisturizing and / or moisturizing substances, fillers that improve the skin feel, fats, oils , Waxes or other usual components of a cosmetic or dermatological formulation such as alcohols
  • Advantageous preservatives in the sense of the present invention are, for example, formaldehyde releasers (such as, for example, DMDM hydantoin, which is available, for example, from Lonza under the trade name Glydant TM), iodopropylbutyl carbamate (for example those under the trade names Glycacil-L , Glycacil-S available from Lonza and / or Dekaben LMB from Jan Dekker), parabens (ie alkyl p-hydroxybenzoate such as methyl, ethyl, propyl and / or butyl paraben), phenoxyethanol, ethanol, benzoic acid and the like , Usually includes the preservation system according to the invention also advantageously preservation aids, such as octoxyglycerol, glycine soy etc.
  • preservation aids such as octoxyglycerol, glycine soy etc.
  • Advantageous complexing agents for the purposes of the present invention are, for example, EDTA, [S, S] -ethylenediamine disuccinate (EDDS), which is available, for example, from Octel under the trade name Octaquest, pentasodium-ethylenediaminetetramethylenephosphonate, which, for. B. is available under the trade name Dequest 2046 from Monsanto and / or iminodisuccinic acid, which u. a. is firmly available from Bayer AG under the trade names Iminodisuccinat VP OC 370 (approx. 30% solution) and Baypure CX 100.
  • EDDS EDTA
  • [S, S] -ethylenediamine disuccinate (EDDS) which is available, for example, from Octel under the trade name Octaquest
  • pentasodium-ethylenediaminetetramethylenephosphonate which, for. B.
  • Dequest 2046 from Monsanto and / or iminodis
  • the hydrodispersions according to the invention can also contain antioxidants.
  • all the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.
  • the antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L- Carnosine and its derivatives (e.g. anserine), carotenoids, carotenes (e.g. ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g.
  • amino acids eg glycine, histidine, tyrosine, tryptophan
  • imidazoles eg urocanic acid
  • peptides such as D, L-carnosine, D-carnosine, L- Carnosine and its derivatives (e.g. anserine)
  • carotenoids e.g
  • thiols e.g. Thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters
  • salts dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthionine sulfoximines, homocystone sulfoximine, pentahionine sulfone
  • sulfoximine compounds eg buthionine sulfoximines, homocystone
  • chelators e.g. -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin
  • ⁇ -hydroxy acids e.g. citronic acid, lactic acid, malic acid
  • unsaturated fatty acids and their derivatives eg ⁇ -uenolenic acid, linoleic acid, oleic acid
  • folic acid and their derivatives Ubi- quinone and ubiquinol and their derivatives
  • vitamin C and derivatives e.g.
  • the amount of the aforementioned antioxidants (one or more compounds) in the preparations according to the invention is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight of the preparation.
  • vitamin E and / or its derivatives represent the antioxidant (s)
  • vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to use their respective concentrations in the range from 0.001 to 10% by weight, based on the total weight of the formulation. to choose.
  • the cosmetic preparations according to the present invention contain cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin from oxidative stress.
  • active ingredients in the sense of the present invention are natural active ingredients and / or their derivatives, such as.
  • Recipes according to the invention which, for. B. known anti-wrinkle active ingredients such as flavone glycosides (especially ⁇ -glycosylrutin), coenzyme Q10, vitamin E and / or derivatives and the like are particularly suitable for the prophylaxis and treatment of cosmetic or dermatological skin changes, such as z. B. occur with skin aging (such as dryness, roughness and formation of dry lines, itching, reduced re-greasing (e.g. after washing), visible vasodilation (telangiectasia, cuperosis), flaccidity and formation of wrinkles and fine lines, local hyper- , Hypo and incorrect pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like). They are also advantageous against the appearance of dry or rough skin.
  • the water phase of the preparations according to the present invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyols having a low C number, and their ethers, preferably propylene glycol, glycerol, butylene glycol - Kol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or mono ethyl ether and analog products, polymers, foam stabilizers and electrolytes.
  • customary cosmetic auxiliaries such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyols having a low C number, and their ethers, preferably propylene glycol, glycerol,
  • the preparations according to the present invention can furthermore advantageously also contain self-tanning substances, such as, for example, dihydroxyacteon and / or melanin derivatives in concentrations of 1% by weight to 8% by weight, based on the total weight of the preparation.
  • self-tanning substances such as, for example, dihydroxyacteon and / or melanin derivatives in concentrations of 1% by weight to 8% by weight, based on the total weight of the preparation.
  • the preparations according to the present invention can also advantageously contain repellents for protection against mosquitoes, ticks and spiders and the like.
  • Z are advantageous.
  • the repellents can be used both individually and in combination.
  • Moisturizers are substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing the moisture release of the horny layer (also known as transepidermal water loss (TEWL)) and / or hydrating the layer of the skin after application or distribution on the skin surface to positively influence.
  • TEWL transepidermal water loss
  • moisturizers for the purposes of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidone carboxylic acid and urea.
  • polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gelable polysaccharides.
  • hyaluronic acid chitosan
  • Starch hydroxypropyltrimonium chloride and / or a fucose-rich polysaccharide
  • Fucogel®1000 from the company SOLABIA S.A. is available.
  • Moisturizers can also advantageously be used as anti-wrinkle agents for the prophylaxis and treatment of cosmetic or dermatological skin changes, such as those described for example in US Pat. B. occur in skin aging, are used.
  • the cosmetic or dermatological preparations according to the invention can furthermore advantageously, although not necessarily, contain fillers which, for. B. further improve the sensory and cosmetic properties of the formulations and, for example, cause or intensify a velvety or silky feeling on the skin.
  • Advantageous fillers for the purposes of the present invention are starch and starch derivatives (such as, for example, tapioca starch, distarch phosphate, aluminum or sodium starch, octenyl succinate and the like), pigments which have neither mainly UV filter nor coloring effects (such as e.g. boron nitride etc.) and / or Aerosile ® (CAS No. 7631-86-9).
  • preparations which are in the form of cleaning emulsions and which advantageously do not contain detergent surfactants, but are advantageous, for example, for removing make-up and / or make-up are also advantageous. up or as a mild wash foam - possibly also for blemished skin.
  • cleaning emulsions can also advantageously be used as so-called “rinse-off preparations, which are rinsed off the skin after use.
  • Cosmetic and dermatological preparations in the form of a sunscreen are also favorable. However, it is also advantageous for the purposes of the present invention to produce cosmetic and dermatological preparations whose main purpose is not protection against sunlight, but which nevertheless contain other UV protection substances. So z. B. in day creams or makeup products usually incorporated UV-A or UV-B filter substances. UV protection substances, like antioxidants and, if desired, preservatives, also provide effective protection of the preparations themselves against spoilage. Cosmetic and dermatological preparations which are in the form of a sunscreen are also favorable.
  • the preparations in the sense of the present invention preferably contain at least one further UV-A, UV-B and / or broadband filter substance.
  • the formulations may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase.
  • the preparations according to the present invention can furthermore advantageously also be in the form of so-called oil-free cosmetic or dermatological emulsions which contain a water phase and at least one UV filter substance which is liquid at room temperature as a further phase and which, in particular, can advantageously also be free of further oil components.
  • Preferred inorganic pigments are metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular oxides of titanium (Ti0 2 ), zinc (ZnO), iron (e.g. Fe 2 0 3 ), zirconium (Zr0 2 ), silicon ( Si0 2 ), manganese (e.g. MnO), aluminum (Al 2 ⁇ 3), cerium (e.g. Ce 2 0 3 ), mixed oxides of the corresponding metals as well as mixtures of such oxides and the sulfate of barium (BaS0 4 ) ,
  • the pigments can also advantageously be used in the form of commercially available oily or aqueous predispersions. Dispersing aids and / or solubilizing agents can advantageously be added to these predispersions.
  • the pigments can advantageously be surface-treated (“coated”), with a hydrophilic, amphiphilic or hydrophobic character being formed or retained, for example.
  • This surface treatment can consist in that the pigments are prepared using a thin hydrophilic and / or hydrophobic inorganic and / or organic layer
  • the various surface coatings can also contain water for the purposes of the present invention.
  • Inorganic surface coatings in the sense of the present invention can consist of aluminum oxide (Al 2 0 3 ), aluminum hydroxide Al (OH) 3 , or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2), sodium hexametaphosphate (NaP0 3 ) ⁇ , sodium metaphosphate (NaP0 3 ) n , silicon dioxide (Si0 2 ) (also: silica, CAS No .: 7631-86- 9), or iron oxide (Fe 2 0 3 ).
  • Al 2 0 3 aluminum oxide
  • Al (OH) 3 aluminum hydroxide Al
  • aluminum oxide hydrate also: alumina, CAS no .: 1333-84-2
  • sodium hexametaphosphate NaP0 3
  • sodium metaphosphate NaP0 3
  • silicon dioxide Si0 2
  • Si0 2 also: silica, CAS No .: 7631-86- 9
  • iron oxide Fe 2 0 3
  • Organic surface coatings in the sense of the present invention can consist of vegetable or animal aluminum stearate, vegetable or animal Stearic acid, lauric acid, dimethylpolysiloxane (also: Dimethicone), methylpolysiloxane (Methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane units and silica gel) or alginic acid.
  • dimethylpolysiloxane also: Dimethicone
  • methylpolysiloxane Metalone
  • simethicone a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane units and silica gel
  • alginic acid can occur alone, in combination and / or in combination with inorganic coating materials.
  • Zinc oxide particles and predispersions of zinc oxide particles suitable according to the invention are available under the following trade names from the companies listed:
  • Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available under the following trade names from the companies listed:
  • Latex particles which are advantageous according to the invention are those described in the following documents: US Pat. No. 5,663,213 and EP 0 761 201. Particularly advantageous latex particles are those which are composed of water and styrene. rol / acrylate copolymers are formed and z. B. are available under the trade name "Alliance SunSphere” from Rohm & Haas.
  • UV-A filter substances for the purposes of the present invention are dibenzoyl methane derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS No. 70356-09-1), which is available from Givaudan under the Parsol brand ® 1789 and is sold by Merck under the trade name Eusolex® 9020.
  • dibenzoyl methane derivatives in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS No. 70356-09-1), which is available from Givaudan under the Parsol brand ® 1789 and is sold by Merck under the trade name Eusolex® 9020.
  • UV filter substances in the sense of the present invention are sulfonated, water-soluble UV filters, such as, for. B .:
  • 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) -benzene also: 3,3 '- (1,4-phenylenedimethylene)) -bis- (7,7-dimethyl-2- oxo-bicyclo- [2.2.1] hept-1-ylmethane sulfonic acid) and its salts (especially the corresponding 10-sulfato compounds, especially the corresponding sodium, potassium or triethanolammonium salt), which is also called benzene-1, 4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) Benzene-1,4-di (2-oxo-3-bornylidenemethyl-10-sulfonic acid) has the INCI name terephthalidene dicampher sulfonic acid ( CAS.-No .: 90457-82-2) and is available, for example, under the trade name Mexoryl SX from Chimex;
  • Sulfonic acid derivatives of 3-benzylidene camphor such as. B. 4- (2-oxo-3-bornylidene-methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidene-methyl) sulfonic acid and salts thereof.
  • Advantageous UV filter substances in the sense of the present invention are fe benzoxazole derivatives, which are characterized by the following structural formula,
  • R 1 , R 2 and R 3 are independently selected from the group of branched or unbranched, saturated or unsaturated alkyl radicals having 1 to 10 carbon atoms. It is particularly advantageous according to the invention to choose the radicals R 1 and R 2 the same, in particular from the group of the branched alkyl radicals having 3 to 5 carbon atoms. It is furthermore particularly advantageous for the purposes of the present invention if R 3 is an unbranched or branched alkyl radical having 8 carbon atoms, in particular the 2-ethylhexyl radical.
  • Benzoxazole derivative which is particularly preferred according to the invention is 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1, 3,5-triazine with CAS No. 288254-16-0, which is characterized by the structural formula
  • the benzoxazole derivative or derivatives are advantageously present in dissolved form in the cosmetic preparations according to the invention. However, it may also be advantageous if the benzoxazole derivative or derivatives in pigmentary, ie. H. undissolved form - for example in particle sizes from 10 nm to 300 nm - are present.
  • UV filter substances in the sense of the present invention are also so-called hydroxybenzophenones.
  • Hydroxybenzophenones are characterized by the following structural formula:
  • R 1 and R 2 are independently hydrogen, CrC ⁇ -alkyl, C 3 -C ⁇ 0 cycloalkyl or C 3 -C 10 cycloalkenyl, wherein the substituents R 1 and R 2, together with the nitrogen atom to which they are attached can form a 5- or 6-ring and R 3 is a C 1 -C 2 o-alkyl radical.
  • a particularly advantageous hydroxybenzophenone in the sense of the present invention is 2- (4'-diethylamino-2'-hydoxybenzoyl) benzoic acid hexyl ester (also: aminobenzophenone), which is characterized by the following structure:
  • Advantageous UV filter substances in the sense of the present invention are also so-called broadband filters, i.e. Filter substances that absorb both UV-A and UV-B radiation.
  • Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.
  • An advantageous broadband filter for the purposes of the present invention is also 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1, 1, 3,3-tetramethylbutyl) phenol) ( INCI: methylene bis-benzotriazolyl tetramethylbutylphenol), which is available, for example, under the trade name Tinosorb® M from CIBA-Chemicals GmbH.
  • Another advantageous broadband filter for the purposes of the present invention is 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1-t ( trimethylsilyl) oxy] disiloxanylpropylj-phenol (CAS No .: 155633-54-8) with the INCI name Drometrizole Trisiloxane.
  • the other UV filter substances can be oil-soluble or water-soluble.
  • Advantageous oil-soluble filter substances are e.g. B .:
  • 3-benzylidene camphor derivatives preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;
  • 4-aminobenzoic acid derivatives preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester;
  • Esters of benzalmalonic acid preferably 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester;
  • esters of cinnamic acid preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone and
  • Advantageous water-soluble filter substances are e.g. B .:
  • Sulfonic acid derivatives of 3-benzylidene camphor such as. B. 4- (2-oxo-3-bomylidene methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidene methyl) sulfonic acid and their
  • a further light protection filter substance according to the invention to be used advantageously is ethylhexyl-2-cyano-3,3-diphenyl acrylate, sold under the name Uvinul ® N 539 T is available (octocrylene) from BASF.
  • Particularly advantageous preparations in the sense of the present invention which are distinguished by a high or very high UV-A protection, contain in addition to the or the filter substances according to the invention) preferably further UV-A and / or broadband filters, in particular dibenzoylmethane derivatives [for example the 4- (tert-butyl) -4'-methoxydibenzoylmethane] and / or the 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-triazine and / or phenylene-1,4, bis (2-benzimidazyl) - 3,3'-5,5'-tetrasulfonic acid bis-sodium salt in each case individually or in any combination with one another.
  • dibenzoylmethane derivatives for example the 4- (tert-butyl) -4'-methoxydibenzoylmethane
  • the preparations according to the present invention advantageously contain the substances which absorb UV radiation in the UV-A and / or UV-B range in a total amount of, for. B. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 20 wt .-%, in particular 1.0 to 15.0 wt .-%, each based on the total weight of the preparations to cosmetic To provide preparations that protect the hair or skin from the entire range of ultraviolet radiation.
  • Preparations according to the invention can also advantageously be used as the basis for cosmetic deodorants or antiperspirants, so that in a particular embodiment the present invention relates to hydrodispersions as the basis for cosmetic deodorants.
  • astringents mainly aluminum salts such as aluminum hydroxychloride (aluminum chlorohydrate) - can reduce the formation of sweat. Furthermore, the combination of astringents with antimicrobial substances in one and the same composition is common. Antiperspirants are also advantageous for the purposes of the present invention.
  • the list of active substances or combinations of active substances mentioned should of course not be limiting.
  • the amount of the antiperspirant active ingredients or deodorants (one or more compounds) in the preparations is preferably 0.01 to 30% by weight, particularly preferably 0.1-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
  • the hydrodispersions according to the invention are preferably used as impregnation solutions in combination with “dry” wipes.
  • the wipes can consist of water-soluble, but advantageously water-insoluble materials.
  • the wipes can be smooth, perforated or surface-structured in the sense of the present invention. Particularly advantageous in the sense
  • the present invention relates to wipes which consist of nonwoven, in particular of water jet bonded and / or water jet embossed nonwoven.
  • Such nonwovens can have macro embossments of any desired pattern.
  • the selection to be made depends on the one hand on the impregnation to be applied and on the other hand on the field of application in which the subsequent cloth is to be used.
  • embossed nonwovens are used, large cavities on the surface of the nonwoven and in the nonwoven make it easier for dirt and impurities to be absorbed if the impregnated cloth is run over the skin.
  • the cleaning effect can be increased many times over compared to non-embossed wipes.
  • the cloth has a weight of 35 to 120 g / m 2 , preferably 40 to 60 g / m 2 (measured at 20 ° C ⁇ 2 ° C and with a humidity of the room air of 65% + 5% for 24 hours).
  • the thickness of the fleece is preferably 0.4 mm to 2 mm, in particular 0.6 mm to 0.9 mm.
  • All organic and inorganic fiber materials on a natural and synthetic basis can generally be used as starting materials for the nonwoven fabric of the cloth.
  • examples include viscose, cotton, cellulose, jute, hemp, sisal, silk, wool, polypropylene, polyester, polyethylene terephthalate (PET), aramid, nylon, poly vinyl derivatives, polyurethanes, polylactide, polyhydroxyalkanoate, cellulose esters and / or polyethylene as well as mineral fibers such as glass fibers or carbon fibers.
  • PET polyethylene terephthalate
  • aramid nylon
  • poly vinyl derivatives polyurethanes
  • polylactide polyhydroxyalkanoate
  • cellulose esters polyhydroxyalkanoate
  • / or polyethylene as well as mineral fibers such as glass fibers or carbon fibers.
  • the present invention is not limited to the materials mentioned, but a large number of further fibers can be used for the formation of nonwovens. For the purposes of the present invention, it is particularly advantageous if the
  • the fibers consist of a mixture of 70% by weight viscose and 30% by weight PET.
  • Nonwovens made of PET, viscose and cotton are also preferred, for example those made of 40% by weight of PET, 50% by weight of viscose and 10% by weight of cotton or those made of 50% by weight of PET, 40% by weight of viscose and 10% by weight cotton.
  • Fibers made of high-strength polymers such as polyamide, polyester and / or highly stretched polyethylene are also particularly advantageous.
  • the fibers can also be colored in order to emphasize and / or increase the visual attractiveness of the fleece.
  • the fibers can additionally contain UV stabilizers and / or preservatives.
  • the fibers used to form the cloth preferably have a water absorption rate of more than 60 mm / [10 min] (measured with the EDANA Test 10.1-72), in particular more than 80 mm / [10 min].
  • the fibers used to form the cloth preferably have a water absorption capacity of more than 5 g / g (measured with the EDANA test 10.1-72), in particular more than 8 g / g.
  • impregnation solutions according to the invention have a viscosity of less than 2000 mPa s. Such impregnation solutions can be applied to the cloth in a manner known per se.
  • wipes according to the invention for cleaning and care of the skin and the use of wipes according to the invention as facial wipes, baby wipes, intimate wipes, deodorant wipes, sun protection wipes and / or wipes for the care and / or cleaning of sensitive skin is also according to the invention.
  • pigments such as, for. B. ZnO
  • the application of zinc oxide is particularly preferred when the wipes according to the invention are to be used in baby care.
  • ZnO which is known for its antibacterial properties, provides additional protection against diaper rash during daily cleaning.
  • Phenylbenzimidazole sulfonic acid 2.00 1.50 1, ⁇
  • Vitamin E acetate 1.00 1.00 o
  • Phenoxyethanol 0.40 0.00 0.00.
  • Example 5-8 further formulations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
EP03796094A 2002-12-17 2003-12-11 Preparations cosmetiques ou dermatologiques tres fluides de type huile-dans-eau Ceased EP1581176A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10258868 2002-12-17
DE2002158868 DE10258868A1 (de) 2002-12-17 2002-12-17 Dünnflüssige kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
PCT/EP2003/050985 WO2004054536A2 (fr) 2002-12-17 2003-12-11 Preparations cosmetiques ou dermatologiques tres fluides de type huile-dans-eau

Publications (1)

Publication Number Publication Date
EP1581176A2 true EP1581176A2 (fr) 2005-10-05

Family

ID=32403836

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03796094A Ceased EP1581176A2 (fr) 2002-12-17 2003-12-11 Preparations cosmetiques ou dermatologiques tres fluides de type huile-dans-eau

Country Status (3)

Country Link
EP (1) EP1581176A2 (fr)
DE (1) DE10258868A1 (fr)
WO (1) WO2004054536A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004002997A1 (de) * 2004-01-19 2005-08-04 Beiersdorf Ag Dünnflüssige W/O Emulsionen ohne O/W-Emulgatoren
DE102005053152A1 (de) * 2005-11-04 2007-05-16 Henkel Kgaa Öl-in-Wasser Emulsionen
EP2537510B1 (fr) 2011-06-24 2017-03-01 Sca Tissue France Composition de nettoyage personnel comprenant des agents gélifiant et moussant pour l'imprégnation de papier

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206128A2 (fr) * 1985-06-18 1986-12-30 Henkel Kommanditgesellschaft auf Aktien Préparations cosmétiques présentant une viscosité spécifique
EP0328355A2 (fr) * 1988-02-10 1989-08-16 Richardson Vicks, Inc. Compositions d'émulsions contenant des agents émulsionants amphipathiques
WO1996002223A1 (fr) * 1994-07-16 1996-02-01 Beiersdorf Ag Preparations cosmetiques ou dermatologiques finement dispersees, exemptes d'emulsifiants, du type huile dans eau
EP0835647A1 (fr) * 1996-10-14 1998-04-15 L'oreal Crème auto-moussante
EP1291007A1 (fr) * 2001-09-07 2003-03-12 Basf Aktiengesellschaft Systèmes du type H/E ne contenant pas ou peu d'émulsifiant et contenant des agents de stabilisation et une hydroxybenzophénone aminosubstituée

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19704038C1 (de) * 1997-02-04 1998-07-09 Goldwell Gmbh Haarbehandlungsmittel und Verfahren zur Haarbehandlung
DE19805918A1 (de) * 1998-02-13 1999-08-19 Beiersdorf Ag Lipidreduzierte Zubereitungen
DE19852212A1 (de) * 1998-11-12 2000-05-18 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, enthaltend ferner ein oder mehrere Alkylmethiconcopolyole und/oder Alkyl-Dimethiconpolyole sowie kationische Polymere
DE19938756A1 (de) * 1999-08-16 2001-02-22 Beiersdorf Ag Dünnflüssige kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
DE19938757A1 (de) * 1999-08-16 2001-02-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
DE10049056A1 (de) * 2000-10-04 2002-04-11 Beiersdorf Ag Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt enthaltend Polyetherpolester sowie mindestens einer Substanz gewählt aus der Gruppe der anionischen und/oder amphoteren Polymere
DE10059584A1 (de) * 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
DE10214053A1 (de) * 2002-03-28 2003-10-09 Beiersdorf Ag Wasserfeste kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Acrylat-Alkylmethacrylat-Copolymeren

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206128A2 (fr) * 1985-06-18 1986-12-30 Henkel Kommanditgesellschaft auf Aktien Préparations cosmétiques présentant une viscosité spécifique
EP0328355A2 (fr) * 1988-02-10 1989-08-16 Richardson Vicks, Inc. Compositions d'émulsions contenant des agents émulsionants amphipathiques
WO1996002223A1 (fr) * 1994-07-16 1996-02-01 Beiersdorf Ag Preparations cosmetiques ou dermatologiques finement dispersees, exemptes d'emulsifiants, du type huile dans eau
EP0835647A1 (fr) * 1996-10-14 1998-04-15 L'oreal Crème auto-moussante
EP1291007A1 (fr) * 2001-09-07 2003-03-12 Basf Aktiengesellschaft Systèmes du type H/E ne contenant pas ou peu d'émulsifiant et contenant des agents de stabilisation et une hydroxybenzophénone aminosubstituée

Also Published As

Publication number Publication date
DE10258868A1 (de) 2004-07-01
WO2004054536A2 (fr) 2004-07-01

Similar Documents

Publication Publication Date Title
EP1534217B1 (fr) Preparations cosmetiques ou dermatologiques fluides du type huile dans l'eau
EP1458340A1 (fr) Formulations cosmetiques et dermatologiques a effet de protection solaire, contenant des derives de bis-resorcinyltriazine et des derives de benzoxazole
EP1458345A1 (fr) Formulations cosmetiques et dermatologiques a effet de protection solaire, contenant des substances filtrant les u.v., solubles dans l'eau et des derives de benzoxazole
EP1380288B1 (fr) Compositions cosmétiques et dermatologiques de protection solaire contenant des Polymeres d'acide acrylamidométhylpropane sulfonique (AMPS) hydrophobes
EP1458341A1 (fr) Formulations cosmetiques et dermatologiques de protection solaire contenant des benzotriazoles et des derives de benzoxazole
DE10247695A1 (de) Emulsion mit substituierten Sacchariden
DE10234885A1 (de) Kosmetische und/oder dermatologische Zubereitung
WO2003053390A1 (fr) Formulations cosmetiques et dermatologiques de protection contre la lumiere contenant des derives benzoxazol
EP1458342A1 (fr) Formulations de protection solaire cosmetiques et dermatologiques contenant des hydroxylbenzophenones et des derives de benzoxazol
WO2004045564A1 (fr) Concentre cosmetique
DE10307468A1 (de) Kosmetische und dermatologische Emulsionen
WO2004045570A1 (fr) Concentre de protection contre la lumiere contenant des polymeres solubles dans l'eau
DE10206798A1 (de) Zweiphasige Sonnenschutzzubereitungen mit O/W-Emulsion
DE10206796A1 (de) Zweiphasige Sonnenschutzzubereitungen mit W/O-Emulsion
DE10214058A1 (de) Wasserfeste kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Polyoxyethylen-Polydodecylglykol-Blockpolymeren
WO2004054536A2 (fr) Preparations cosmetiques ou dermatologiques tres fluides de type huile-dans-eau
WO2003082237A2 (fr) Formulations de protection solaire cosmetiques et dermatologiques hydroresistantes contenant une quantite d'esters acetyles de l'acide stearique
WO2005067883A1 (fr) Visualisation d'agents de protection solaire sur la peau
DE10252235A1 (de) Emulgatorkombination
DE10307467A1 (de) Kosmetische und dermatologische Emulsionen
DE102004002600A1 (de) Visualisierung von Sonnenschutzmitteln auf der Haut
DE10206795A1 (de) Zweiphasige kosmetische oder dermatologische Zubereitungen mit einer Mikroemulsion
DE102004002601A1 (de) Visualisierung von Sonnenschutzmitteln auf der Haut
WO2005067882A1 (fr) Visualisation d'agents de protection solaire sur la peau
DE10230061A1 (de) Kosmetische oder dermatologische Formulierungen zur Pflege der Gesichtshaut

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050302

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20110415

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20150915